During the past decade, Arcispedale Santa Maria Nuova conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 29 clinical trials were completed, i.e. on average, 30.9% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 20 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arcispedale Santa Maria Nuova" #1 sponsor was "Celgene" with 16 trials, followed by "Mario Negri Institute for Pharmacological Research" with 10 trials sponsored, "Arcispedale Santa Maria Nuova-IRCCS" with 9 trials sponsored, "International Extranodal Lymphoma Study Group (IELSG)" with 8 trials sponsored and "Fondazione Italiana Linfomi ONLUS" with 8 trials sponsored. Other sponsors include 122 different institutions and companies that sponsored additional 88 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arcispedale Santa Maria Nuova" #1 collaborator was "Arcispedale Santa Maria Nuova-IRCCS" with 6 trials as a collaborator, "Agenzia Italiana del Farmaco" with 3 trials as a collaborator, "Clinical Research Technology S.r.l." with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Arcispedale Santa Maria Nuova" are "Multiple Myeloma" (9 trials), "Breast Cancer" (6 trials), "Ovarian Cancer" (6 trials), "Follicular Lymphoma" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Arcispedale Santa Maria Nuova" in a lesser frequency.

Most popular intervention types in "Arcispedale Santa Maria Nuova" are "Drug" (125 trials), "Other" (17 trials), "Device" (12 trials), "Biological" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Carboplatin" (10 trials), "Gemcitabine" (8 trials), "Paclitaxel" (8 trials) and "Dexamethasone" (7 trials). Other intervention names were less common.

The vast majority of trials in "Arcispedale Santa Maria Nuova" are 149 trials for "All" genders, 26 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Arcispedale Santa Maria Nuova". 1 are not yet recruiting, 26 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in Arcispedale Santa Maria Nuova, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Arcispedale Santa Maria Nuova, 10 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 11 trials that are defined as “Not Applicable".